We are PACT: the Partnership for Advancing Clinical Trials, a consortium of more than 30 biopharmaceutical organizations (and growing). We are working together to gather data on and measure the impact of DCT (Decentralized Clinical Trial) solutions on clinical trial performance.

Join our consortium to participate in upcoming events, receive the latest updates on our findings, and be a part of our research.

The PACT Consortium is a much-needed source for granular and hard evidence on the hybrid use and impact of DCT solutions, and the data provided by consortium members is already demonstrating the value proposition of DCTs.”

Ken Getz, Executive Director and Professor, Tufts CSDD